Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel Treatment Options in Head and Neck Cancer.
Schuler PJ, Laban S, Doescher J, Bullinger L, Hoffmann TK. Schuler PJ, et al. Among authors: bullinger l. Oncol Res Treat. 2017;40(6):342-346. doi: 10.1159/000477254. Epub 2017 May 17. Oncol Res Treat. 2017. PMID: 28521322 Review.
Response Evaluation in Head and Neck Oncology: Definition and Prediction.
Hoffmann TK, Schuler PJ, Laban S, Grässlin R, Beer M, Beer AJ, Friebe-Hoffmann U, Bullinger L, Möller P, Wiegel T. Hoffmann TK, et al. Among authors: bullinger l. ORL J Otorhinolaryngol Relat Spec. 2017;79(1-2):14-23. doi: 10.1159/000455726. Epub 2017 Feb 24. ORL J Otorhinolaryngol Relat Spec. 2017. PMID: 28231577 Review.
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer.
Doescher J, Weissinger SE, Schönsteiner SS, Lisson C, Bullinger L, Barth TF, Leithäuser F, Mueller-Richter U, Laban S, Hoffmann TK, Möller P, Lennerz JK, Schuler PJ. Doescher J, et al. Among authors: bullinger l. Immunotherapy. 2019 Oct;11(14):1193-1203. doi: 10.2217/imt-2019-0041. Epub 2019 Aug 29. Immunotherapy. 2019. PMID: 31462115 Clinical Trial.
Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib.
Böhm MJ, Marienfeld R, Jäger D, Mellert K, von Witzleben A, Brüderlein S, Wittau M, von Baer A, Schultheiss M, Mayer-Steinacker R, Rücker FG, Möller P, Bullinger L, Barth TFE. Böhm MJ, et al. Among authors: bullinger l. Sarcoma. 2019 Jan 21;2019:3914232. doi: 10.1155/2019/3914232. eCollection 2019. Sarcoma. 2019. PMID: 30804704 Free PMC article.
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Möller P, Stilgenbauer S, Pollack JR, Wirth T. Sander S, et al. Among authors: bullinger l. Blood. 2008 Nov 15;112(10):4202-12. doi: 10.1182/blood-2008-03-147645. Epub 2008 Aug 19. Blood. 2008. PMID: 18713946 Free article.
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
Sander S, Bullinger L, Leupolt E, Benner A, Kienle D, Katzenberger T, Kalla J, Ott G, Müller-Hermelink HK, Barth TF, Möller P, Lichter P, Döhner H, Stilgenbauer S. Sander S, et al. Among authors: bullinger l. Haematologica. 2008 May;93(5):680-7. doi: 10.3324/haematol.12330. Epub 2008 Mar 26. Haematologica. 2008. PMID: 18367489 Free article.
385 results